Prion infection-impaired functional blocks identified by proteomics enlighten the targets and the curing pathways of an anti-prion drug

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1774, Issue 1, 2007, Pages 154-167

  Chich, J F ^a   Schaeffer, B ^b   Bouin, A P ^c   Mouthon, F ^d   Labas, V ^e   Larramendy, C ^d   Deslys, J P ^d   Grosclaude, J ^a  

^a INRA Institut National de la Recherche Agronomique   (France)

^b UR341 National Agronomical Research Institute (INRA)   (France)

^c LABORATOIRE HÉTÉROÉLÉMENTS ET COORDINATION   (France)

^d INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

^e PSL RESEARCH UNIVERSITY   (France)

Author keywords

Heparan sulfate mimetics; Neuronal cell line; Prion; Proteomics

Indexed keywords

HEAT SHOCK PROTEIN; HEPARAN SULFATE; HEPARAN SULFATE MIMETIC AGENT; PRION PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; DEGENERATIVE DISEASE; DNA REPLICATION; DRUG TARGETING; NERVE CELL CULTURE; NEUROLOGIC DISEASE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRION DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; SOLUBILITY; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ANIMALIA;

EID: 33845979139     PISSN: 15709639     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbapap.2006.10.016     Document Type: Article

References (78)

1. Prusiner S.B., Scott M.R., DeArmond S.J., and Cohen F.E. Prion protein biology. Cell 93 (1998) 337-348
2. Adjou K.T., Simoneau S., Sales N., Lamoury F., Dormont D., Papy-Garcia D., Barritault D., Deslys J.P., and Lasmezas C.I. A novel generation of heparan sulfate mimetics for the treatment of prion diseases. J. Gen. Virol. 84 (2003) 2595-2603
3. Mange A., Milhavet O., McMahon H.E., Casanova D., and Lehmann S. Effect of amphotericin B on wild-type and mutated prion proteins in cultured cells: putative mechanism of action in transmissible spongiform encephalopathies. J. Neurochem. 74 (2000) 754-762
4. Sellarajah S., Lekishvili T., Bowring C., Thompsett A.R., Rudyk H., Birkett C.R., Brown D.R., and Gilbert I.H. Synthesis of analogues of Congo red and evaluation of their anti-prion activity. J. Med. Chem. 47 (2004) 5515-5534
5. Barret A., Tagliavini F., Forloni G., Bate C., Salmona M., Colombo L., De Luigi A., Limido L., Suardi S., Rossi G., Auvre F., Adjou K.T., Sales N., Williams A., Lasmezas C., and Deslys J.P. Evaluation of quinacrine treatment for prion diseases. J. Virol. 77 (2003) 8462-8469
6. Soto C., Kascsak R.J., Saborio G.P., Aucouturier P., Wisniewski T., Prelli F., Kascsak R., Mendez E., Harris D.A., Ironside J., Tagliavini F., Carp R.I., and Frangione B. Reversion of prion protein conformational changes by synthetic beta-sheet breaker peptides. Lancet 355 (2000) 192-197
7. Milhavet O., Mange A., Casanova D., and Lehmann S. Effect of Congo red on wild-type and mutated prion proteins in cultured cells. J. Neurochem. 74 (2000) 222-230
8. Georgieva D., Schwark D., von Bergen M., Redecke L., Genov N., and Betzel C. Interactions of recombinant prions with compounds of therapeutical significance. Biochem. Biophys. Res. Commun. 344 (2006) 463-470
9. Beringue V., Vilette D., Mallinson G., Archer F., Kaisar M., Tayebi M., Jackson G.S., Clarke A.R., Laude H., Collinge J., and Hawke S. PrPSc binding antibodies are potent inhibitors of prion replication in cell lines. J. Biol. Chem. 279 (2004) 39671-39676
10. Kim C.L., Karino A., Ishiguro N., Shinagawa M., Sato M., and Horiuchi M. Cell-surface retention of PrPC by anti-PrP antibody prevents protease-resistant PrP formation. J. Gen. Virol. 85 (2004) 3473-3482
11. Shyng S.L., Lehmann S., Moulder K.L., and Harris D.A. Sulfated glycans stimulate endocytosis of the cellular isoform of the prion protein, PrPC, in cultured cells. J. Biol. Chem. 270 (1995) 30221-30229
12. Bate C., Reid S., and Williams A. Phospholipase A2 inhibitors or platelet-activating factor antagonists prevent prion replication. J. Biol. Chem. 279 (2004) 36405-36411
13. Bate C., Salmona M., Diomede L., and Williams A. Squalestatin cures prion-infected neurons and protects against prion neurotoxicity. J. Biol. Chem. 279 (2004) 14983-14990
14. Mellon P.L., Windle J.J., Goldsmith P.C., Padula C.A., Roberts J.L., and Weiner R.I. Immortalization of hypothalamic GnRH neurons by genetically targeted tumorigenesis. Neuron 5 (1990) 1-10
15. Schatzl H.M., Laszlo L., Holtzman D.M., Tatzelt J., DeArmond S.J., Weiner R.I., Mobley W.C., and Prusiner S.B. A hypothalamic neuronal cell line persistently infected with scrapie prions exhibits apoptosis. J. Virol. 71 (1997) 8821-8831
16. Sandberg M.K., and Low P. Altered interaction and expression of proteins involved in neurosecretion in scrapie-infected GT1-1 cells. J. Biol. Chem. 280 (2005) 1264-1271
17. Schonberger O., Horonchik L., Gabizon R., Papy-Garcia D., Barritault D., and Taraboulos A. Novel heparan mimetics potently inhibit the scrapie prion protein and its endocytosis. Biochem. Biophys. Res. Commun. 312 (2003) 473-479
18. Klohn P.C., Stoltze L., Flechsig E., Enari M., and Weissmann C. A quantitative, highly sensitive cell-based infectivity assay for mouse scrapie prions. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 11666-11671
19. Boyd-Kimball D., Castegna A., Sultana R., Poon H.F., Petroze R., Lynn B.C., Klein J.B., and Butterfield D.A. Proteomic identification of proteins oxidized by Abeta(1-42) in synaptosomes: implications for Alzheimer's disease. Brain Res. 1044 (2005) 206-215
20. Biasini E., Massignan T., Fioriti L., Rossi V., Dossena S., Salmona M., Forloni G., Bonetto V., and Chiesa R. Analysis of the cerebellar proteome in a transgenic mouse model of inherited prion disease reveals preclinical alteration of calcineurin activity. Proteomics 6 (2006) 2823-2834
21. Desgranges P., Barbaud C., Caruelle J.P., Barritault D., and Gautron J. A substituted dextran enhances muscle fiber survival and regeneration in ischemic and denervated rat EDL muscle. FASEB J. 13 (1999) 761-766
22. E. Petit, D. Papy-Garcia and V. Barbier Chassefiere, Procédé de sulfonation de composés comprenant des groupements hydroxyle (OH) libres ou des amines primaires ou secondaires OTR3, Patent no FR2832708 (2002).
23. de Venevelles P., Chich J.F., Faigle W., Loew D., Labbe M., Girard-Misguich F., and Pery P. Towards a reference map of Eimeria tenella sporozoite proteins by two-dimensional electrophoresis and mass spectrometry. Int. J. Parasitol. 34 (2004) 1321-1331
24. Blum H., Beier H., and Gross H.J. Improved silver staining of plant proteins, RNA and DNA in polyacrylamide gels. Electrophoresis 8 (1987) 93-99
25. SAS Institute Inc. pp. 3884, SAS Institute Inc, Cary, NC, USA 1999.
26. Chich J.F., David O., Villers F., Schaeffer B., Lutomski D., and Huet S. Statistics for proteomics: experimental design and 2-DE differential analysis. J. Chromatogr., B. (2006) 10.1016/j.jchromb.2006.09.033
27. Benjamini Y., and Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc., B 57 (1995) 289-300
28. Shevchenko A., Wilm M., Vorm O., Jensen O.N., Podtelejnikov A.V., Neubauer G., Shevchenko A., Mortensen P., and Mann M. A strategy for identifying gel-separated proteins in sequence databases by MS alone. Biochem. Soc. Trans. 24 (1996) 893-896
29. Gasteiger E., Gattiker A., Hoogland C., Ivanyi I., Appel R.D., and Bairoch A. ExPASy: the proteomics server for in-depth protein knowledge and analysis. Nucleic Acids Res. 31 (2003) 3784-3788
30. Blake J.A., Richardson J.E., Bult C.J., Kadin J.A., and Eppig J.T. MGD: the mouse genome database. Nucleic Acids Res. 31 (2003) 193-195
31. Ashburner M., Ball C.A., Blake J.A., Botstein D., Butler H., Cherry J.M., Davis A.P., Dolinski K., Dwight S.S., Eppig J.T., Harris M.A., Hill D.P., Issel-Tarver L., Kasarskis A., Lewis S., Matese J.C., Richardson J.E., Ringwald M., Rubin G.M., and Sherlock G. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 25 (2000) 25-29
32. Al-Shahrour F., Diaz-Uriarte R., and Dopazo J. FatiGO: a web tool for finding significant associations of Gene Ontology terms with groups of genes. Bioinformatics 20 (2004) 578-580
33. von Mering C., Jensen L.J., Snel B., Hooper S.D., Krupp M., Foglierini M., Jouffre N., Huynen M.A., and Bork P. STRING: known and predicted protein-protein associations, integrated and transferred across organisms. Nucleic Acids Res. 33 (2005) D433-D437
34. Hetz C., Russelakis-Carneiro M., Walchli S., Carboni S., Vial-Knecht E., Maundrell K., Castilla J., and Soto C. The disulfide isomerase Grp58 is a protective factor against prion neurotoxicity. J. Neurosci. 25 (2005) 2793-2802
35. Nishida E., Koyasu S., Sakai H., and Yahara I. Calmodulin-regulated binding of the 90-kDa heat shock protein to actin filaments. J. Biol. Chem. 261 (1986) 16033-16036
36. Hetz C., Russelakis-Carneiro M., Maundrell K., Castilla J., and Soto C. Caspase-12 and endoplasmic reticulum stress mediate neurotoxicity of pathological prion protein. EMBO J. 22 (2003) 5435-5445
37. Mazzarella R.A., Srinivasan M., Haugejorden S.M., and Green M. ERp72, an abundant luminal endoplasmic reticulum protein, contains three copies of the active site sequences of protein disulfide isomerase. J. Biol. Chem. 265 (1990) 1094-1101
38. Lim J., and Lu K.P. Pinning down phosphorylated tau and tauopathies. Biochim. Biophys. Acta 1739 (2005) 311-322
39. Harris S.L., and Levine A.J. The p53 pathway: positive and negative feedback loops. Oncogene 24 (2005) 2899-2908
40. Jeske N.A., Glucksman M.J., and Roberts J.L. Metalloendopeptidase EC 3.4.24.15 is constitutively released from the exofacial leaflet of lipid rafts in GT1-7 cells. J. Neurochem. 90 (2004) 819-828
41. Oliveira V., Garrido P.A., Rodrigues C.C., Colquhoun A., Castro L.M., Almeida P.C., Shida C.S., Juliano M.A., Juliano L., Camargo A.C., Hyslop S., Roberts J.L., Grum-Tokars V., Glucksman M.J., and Ferro E.S. Calcium modulates endopeptidase 24.15 (EC 3.4.24.15) membrane association, secondary structure and substrate specificity. FEBS J. 272 (2005) 2978-2992
42. Rochefort H., and Liaudet-Coopman E. Cathepsin D in cancer metastasis: a protease and a ligand. APMIS 107 (1999) 86-95
43. Ntais C., Polycarpou A., and Ioannidis J.P. Meta-analysis of the association of the cathepsin D Ala224Val gene polymorphism with the risk of Alzheimer's disease: a HuGE gene-disease association review. Am. J. Epidemiol. 159 (2004) 527-536
44. Berg D., Holzmann C., and Riess O. 14-3-3 proteins in the nervous system. Nat. Rev., Neurosci. 4 (2003) 752-762
45. Hsich G., Kenney K., Gibbs C.J., Lee K.H., and Harrington M.G. The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N. Engl. J. Med. 335 (1996) 924-930
46. Bommer U.A., and Thiele B.J. The translationally controlled tumour protein (TCTP). Int. J. Biochem. Cell Biol. 36 (2004) 379-385
47. Noske A., Denkert C., Schober H., Sers C., Zhumabayeva B., Weichert W., Dietel M., and Wiechen K. Loss of gelsolin expression in human ovarian carcinomas. Eur. J. Cancer 41 (2005) 461-469
48. Seelan R.S., Parthasarathy L.K., and Parthasarathy R.N. E2F1 regulation of the human myo-inositol 1-phosphate synthase (ISYNA1) gene promoter. Arch. Biochem. Biophys. 431 (2004) 95-106
49. Janmey P.A., Xian W., and Flanagan L.A. Controlling cytoskeleton structure by phosphoinositide-protein interactions: phosphoinositide binding protein domains and effects of lipid packing. Chem. Phys. Lipids 101 (1999) 93-107
50. Qian Y.W., and Lee E.Y. Dual retinoblastoma-binding proteins with properties related to a negative regulator of ras in yeast. J. Biol. Chem. 270 (1995) 25507-25513
51. Zhu L. Tumour suppressor retinoblastoma protein Rb: a transcriptional regulator. Eur. J. Cancer 41 (2005) 2415-2427
52. Chatenay-Rivauday C., Cakar Z.P., Jeno P., Kuzmenko E.S., and Fiedler K. Caveolae: biochemical analysis. Mol. Biol. Rep. 31 (2004) 67-84
53. Kubista H., Hawkins T.E., Patel D.R., Haigler H.T., and Moss S.E. Annexin 5 mediates a peroxide-induced Ca(2+) influx in B cells. Curr. Biol. 9 (1999) 1403-1406
54. Mulla A., Christian H.C., Solito E., Mendoza N., Morris J.F., and Buckingham J.C. Expression, subcellular localization and phosphorylation status of annexins 1 and 5 in human pituitary adenomas and a growth hormone-secreting carcinoma. Clin. Endocrinol. (Oxf.) 60 (2004) 107-119
55. White A.R., Guirguis R., Brazier M.W., Jobling M.F., Hill A.F., Beyreuther K., Barrow C.J., Masters C.L., Collins S.J., and Cappai R. Sublethal concentrations of prion peptide PrP106-126 or the amyloid beta peptide of Alzheimer's disease activates expression of proapoptotic markers in primary cortical neurons. Neurobiol. Dis. 8 (2001) 299-316
56. Gauczynski S., Peyrin J.M., Haik S., Leucht C., Hundt C., Rieger R., Krasemann S., Deslys J.P., Dormont D., Lasmezas C.I., and Weiss S. The 37-kDa/67-kDa laminin receptor acts as the cell-surface receptor for the cellular prion protein. EMBO J. 20 (2001) 5863-5875
57. Bosque P.J., and Prusiner S.B. Cultured cell sublines highly susceptible to prion infection. J. Virol. 74 (2000) 4377-4386
58. Gourlay C.W., and Ayscough K.R. The actin cytoskeleton in ageing and apoptosis. FEMS Yeast Res. 5 (2005) 1193-1198
59. Morot-Gaudry-Talarmain Y., Rezaei H., Guermonprez L., Treguer E., and Grosclaude J. Selective prion protein binding to synaptic components is modulated by oxidative and nitrosative changes induced by copper(II) and peroxynitrite in cholinergic synaptosomes, unveiling a role for calcineurin B and thioredoxin. J. Neurochem. 87 (2003) 1456-1470
60. Mange A., Crozet C., Lehmann S., and Beranger F. Scrapie-like prion protein is translocated to the nuclei of infected cells independently of proteasome inhibition and interacts with chromatin. J. Cell. Sci. 117 (2004) 2411-2416
61. Pietri M., Schneider B., Mouillet-Richard S., Ermonval M., Mutel V., Launay J.M., and Kellermann O. Reactive oxygen species-dependent TNF-alpha converting enzyme activation through stimulation of 5-HT2B and alpha1D autoreceptors in neuronal cells. FASEB J. 19 (2005) 1078-1087
62. Ben-Zaken O., Tzaban S., Tal Y., Horonchik L., Esko J.D., Vlodavsky I., and Taraboulos A. Cellular heparan sulfate participates in the metabolism of prions. J. Biol. Chem. 278 (2003) 40041-40049
63. Mayer-Sonnenfeld T., Zeigler M., Halimi M., Dayan Y., Herzog C., Lasmezas C.I., and Gabizon R. The metabolism of glycosaminoglycans is impaired in prion diseases. Neurobiol. Dis. 20 (2005) 738-743
64. Yanagishita M. Cellular catabolism of heparan sulfate proteoglycans. Trends Glycosci. Glycotechnol. 10 (1998) 57-63
65. Yamaguchi Y. Heparan sulfate proteoglycans in neural development. Trends Glycosci. Glycotechnol. 10 (1998) 161-173
66. Zucchi I., Mento E., Kuznetsov V.A., Scotti M., Valsecchi V., Simionati B., Vicinanza E., Valle G., Pilotti S., Reinbold R., Vezzoni P., Albertini A., and Dulbecco R. Gene expression profiles of epithelial cells microscopically isolated from a breast-invasive ductal carcinoma and a nodal metastasis. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 18147-18152
67. Liu X., Wu Y., Zehner Z.E., Jackson-Cook C., and Ware J.L. Proteomic analysis of the tumorigenic human prostate cell line M12 after microcell-mediated transfer of chromosome 19 demonstrates reduction of vimentin. Electrophoresis 24 (2003) 3445-3453
68. Takakura S., Kohno T., Manda R., Okamoto A., Tanaka T., and Yokota J. Genetic alterations and expression of the protein phosphatase 1 genes in human cancers. Int. J. Oncol. 18 (2001) 817-824
69. Swanson T.A., Kim S.I., Myers M., Pabon A., Philibert K.D., Wang M., and Glucksman M.J. The role of neuropeptide processing enzymes in endocrine (prostate) cancer: EC 3.4.24.15 (EP24.15). Protein Pept. Lett. 11 (2004) 471-478
70. Diarra-Mehrpour M., Arrabal S., Jalil A., Pinson X., Gaudin C., Pietu G., Pitaval A., Ripoche H., Eloit M., Dormont D., and Chouaib S. Prion protein prevents human breast carcinoma cell line from tumor necrosis factor alpha-induced cell death. Cancer Res. 64 (2004) 719-727
71. Joyce J.A., Freeman C., Meyer-Morse N., Parish C.R., and Hanahan D. A functional heparan sulfate mimetic implicates both heparanase and heparan sulfate in tumor angiogenesis and invasion in a mouse model of multistage cancer. Oncogene 24 (2005) 4037-4051
72. Chen S., Mange A., Dong L., Lehmann S., and Schachner M. Prion protein as trans-interacting partner for neurons is involved in neurite outgrowth and neuronal survival. Mol. Cell. Neurosci. 22 (2003) 227-233
73. Santuccione A., Sytnyk V., Leshchyns'ka I., and Schachner M. Prion protein recruits its neuronal receptor NCAM to lipid rafts to activate p59fyn and to enhance neurite outgrowth. J. Cell Biol. 169 (2005) 341-354
74. Steele A.D., Emsley J.G., Ozdinler P.H., Lindquist S., and Macklis J.D. Prion protein (PrPc) positively regulates neural precursor proliferation during developmental and adult mammalian neurogenesis. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 3416-3421
75. Cotto E., Andre M., Forgue J., Fleury H.J., and Babin P.J. Molecular characterization, phylogenetic relationships, and developmental expression patterns of prion genes in zebrafish (Danio rerio). FEBS J. 272 (2005) 500-513
76. Shakib K., Norman J.T., Fine L.G., Brown L.R., and Godovac-Zimmermann J. Proteomics profiling of nuclear proteins for kidney fibroblasts suggests hypoxia, meiosis, and cancer may meet in the nucleus. Proteomics 5 (2005) 2819-2838
77. Butterfield D.A., and Boyd-Kimball D. Proteomics analysis in Alzheimer's disease: new insights into mechanisms of neurodegeneration. Int. Rev. Neurobiol. 61 (2004) 159-188
78. Choudhary J., and Grant S.G. Proteomics in postgenomic neuroscience: the end of the beginning. Nat. Neurosci. 7 (2004) 440-445